Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Communication Services | 10.92% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Douglas Dynamics
PLOW
$967M
| $2.41M | ﹤0.01% |
52,200
+400
| +0.8% | +$18.4K |
|
1902
Marten Transport
MRTN
$1.24B
| $2.4M | ﹤0.01% |
141,675
+1,800
| +1% | +$30.4K |
|
|
TRHC
1903
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.38M | ﹤0.01% |
51,700
+2,100
| +4% | +$100K |
|
|
ZGNX
1904
DELISTED
Zogenix, Inc.
ZGNX
| $2.36M | ﹤0.01% |
120,900
+1,700
| +1% | +$34.9K |
|
|
GTY
1905
Getty Realty Corp
GTY
$2.05B
| $2.36M | ﹤0.01% |
83,209
+2,700
| +3% | +$75.5K |
|
1906
Veeco
VECO
$3.28B
| $2.35M | ﹤0.01% |
113,421
+1,400
| +1% | +$29.1K |
|
|
TVRD
1907
Tvardi Therapeutics
TVRD
$22.1M
| $2.35M | ﹤0.01% |
3,006
+206
| +7% | +$141K |
|
|
CHCT
1908
Community Healthcare Trust
CHCT
$433M
| $2.35M | ﹤0.01% |
50,900
+2,100
| +4% | +$97.5K |
|
1909
Apogee Enterprises
APOG
$888M
| $2.34M | ﹤0.01% |
57,300
+1,100
| +2% | +$41.6K |
|
|
BBT
1910
Beacon Financial Corp
BBT
$2.71B
| $2.33M | ﹤0.01% |
104,600
+2,200
| +2% | +$44.9K |
|
1911
Parsons
PSN
$5.08B
| $2.33M | ﹤0.01% |
57,600
+600
| +1% | +$22.7K |
|
1912
Ameresco
AMRC
$1.47B
| $2.33M | ﹤0.01% |
47,800
+900
| +2% | +$49.6K |
|
1913
Heritage Financial
HFWA
$1.23B
| $2.31M | ﹤0.01% |
81,768
| – | – |
|
1914
CorVel
CRVL
$3.25B
| $2.31M | ﹤0.01% |
67,500
+600
| +0.9% | +$20.9K |
|
1915
Liberty Energy
LBRT
$3.45B
| $2.31M | ﹤0.01% |
204,200
+50,700
| +33% | +$609K |
|
1916
Simulations Plus
SLP
$370M
| $2.3M | ﹤0.01% |
36,400
+900
| +3% | +$66K |
|
1917
IMAX
IMAX
$2.92B
| $2.3M | ﹤0.01% |
114,400
+1,100
| +1% | +$21.9K |
|
1918
Cerus
CERS
$572M
| $2.29M | ﹤0.01% |
381,900
+6,200
| +2% | +$42.2K |
|
|
STKL
1919
DELISTED
SunOpta
STKL
| $2.29M | ﹤0.01% |
154,925
+2,400
| +2% | +$34.4K |
|
1920
Allegiant Air
ALGT
$2.36B
| $2.28M | ﹤0.01% |
9,328
+200
| +2% | +$44.4K |
|
1921
Wabash National
WNC
$509M
| $2.27M | ﹤0.01% |
121,000
+1,400
| +1% | +$24.8K |
|
1922
Ocular Therapeutix
OCUL
$2.22B
| $2.27M | ﹤0.01% |
138,600
+1,500
| +1% | +$28.9K |
|
1923
Weis Markets
WMK
$1.77B
| $2.26M | ﹤0.01% |
40,000
+400
| +1% | +$21.4K |
|
|
NGD
1924
DELISTED
New Gold Inc
NGD
| $2.26M | ﹤0.01% |
1,463,662
| – | – |
|
1925
Inogen
INGN
$154M
| $2.26M | ﹤0.01% |
43,000
+500
| +1% | +$25K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.